Elsevier,

The Lancet, Volume 400, Issue 10368, 10–16 December 2022, Pages 2137-2146

Interventions targeting the health effects of racism, xenophobia, and discrimination: what, where, and at which level of society?
This Series paper supports SDGs 3 and 10 by focusing on wider societal action to confront the health effects of racism, highlighting that broader, deeper, transformative action is needed compared with current measures to tackle the adverse effects of racism on health.
Cabotegravir (CAB) is an integrase strand transfer inhibitor (INSTI) formulated as a long-acting injectable drug approved for pre-exposure prophylaxis and use with a long acting rilpivirine formulation for therapy in patients with virological suppression. However, there has been no comprehensive review of the genetic mechanisms of CAB resistance. Studies reporting the selection of drug resistance mutations (DRMs) by CAB and the results of in vitro CAB susceptibility testing were reviewed.
An ongoing challenge in HIV-1 vaccine research is finding a novel HIV-1 envelope glycoprotein (Env)-based immunogen that elicits broadly cross-neutralizing antibodies (bnAbs) without requiring complex sequential immunization regimens to drive the required antibody affinity maturation. 
This Article supports SDG 8,9 and 10, by examining the direct relation between economic inequity and burden of disease due to air pollution in India considering time trends from 2011-2019.
Elsevier,

Clinical Breast Cancer, Volume 23, Issue 2, February 2023, Pages 181-188

This Study supports SDGs 3, 5 and 10 by exploring the national impact of limited English proficiency (LEP) in breast cancer screening. Previously unknown, the results showed that LEP women, particularly Spanish speakers, are associated with a lower probability of having a screening mammogram.
Elsevier,

Clinical Breast Cancer, Volume 23, Issue 2, February 2023, Pages 211-218

This Study supports SDGs 3, 5 and 10 by highlighting the significant variability in insurance coverage of Prophylactic Mastectomy (PM) between companies which can lead to further inequalities in access to this breast cancer risk reducing procedure. Physicians and patients alike should advocate for fair and equal access to PM for certain clinical indications.
This Article supports SDGs 3, 5 and 10, summarizing a discussion on workplace flexibility held by the AAWR at the RSNA 2021 Scientific Assembly and Annual Meeting, and highlighting the positive impact various aspects of flexible work arrangements have on women.
Elsevier,

The Lancet Global Health, Volume 11, Issue 1, January 2023, Pages e155-e164 

Framework for the use of imagery in global health
This Health Policy paper supports SDGs 3 and 10; the authors did an empirical analysis of the use of imagery by key global health stakeholders and showed that the narrative currently depicted in imagery is one of power imbalances, depicting women and children from low-income and middle-income countries with less dignity, respect, and power than those from high-income countries.
The criminalization of women’s healthcare in many USA states has created uncertainty about women’s access to evidence-based medical care and will affect the physical, mental, and emotional health and well-being of women. This article is intended to start a discussion on this complex topic in the immunology community.
This Article supports SDG 3 and 10 by highlighting the need for age-appropriate Indigenous strategies to improve health outcomes and reduce inequities for rangatahi Māori. This study provides an overview of Indigenous youth trends in Aotearoa New Zealand over two decades utilising repeated series of cross-sectional and representative surveys of secondary school students. Health inequities persisted over the 19-year period for rangatahi Māori, when compared to their Pākehā (NZ European /other European/“White”) peers, with few exceptions. 

Pages